Rapid Nutrition Taps Bowsprit Partners to Steer Post-Investment Growth

LONDON, UK – April 14, 2026 – In a strategic move signaling a new chapter of expansion, global HealthTech company Rapid Nutrition PLC has appointed Bowsprit Partners as its Financial Adviser and Corporate Broker. The appointment comes on the heels of a recent €5 million cornerstone investment, underscoring the company's intent to aggressively scale its international operations and solidify its position in the competitive wellness market.

Rapid Nutrition, which trades on the Euronext Growth exchange in Paris under the ticker ALRPD, is positioning itself for what its leadership calls its “next phase of growth.” The engagement of Bowsprit Partners, a London-based and FCA-authorised advisory firm, is a critical step in building a more robust capital markets infrastructure. This framework is designed to support the company’s ambitious strategic roadmap, which includes expanding its technology-enabled wellness solutions and evidence-based nutrition brands across the globe.

This development follows a period of significant activity for the company, including a 1,000:1 share consolidation and a temporary trading suspension by the French financial markets authority, the AMF, which was lifted on April 10. By bringing in a recognized Euronext Listing Sponsor with cross-border expertise, Rapid Nutrition is sending a clear message to the market about its commitment to enhanced governance and disciplined execution.

A Strategic Pivot for Global Ambitions

The appointment is fundamentally tied to Rapid Nutrition’s evolving business model. The company is transitioning from a premium nutraceuticals business into a personalized, platform-led HealthTech operator. This strategy leverages artificial intelligence and clinical research to deliver customized nutrition and wellness solutions, moving beyond its established brands like the SystemLS weight management system and the Azurene immunity booster.

The recent €5 million long-term cornerstone investment, secured in January from an undisclosed investor, provides the financial firepower for this pivot. The capital is earmarked to accelerate international expansion and scale the company's omni-channel footprint in key markets, including Australia, the United States, and China. The firm is pursuing a hybrid growth model that combines organic product development with a strategic “buy-and-build” approach to acquire complementary businesses and technologies.

In the official announcement, Simon St Ledger, Executive Director and CEO of Rapid Nutrition, emphasized the timing and strategic importance of the move. “Following the successful completion of our cornerstone investment, the Board has focused on ensuring that our capital markets framework evolves alongside the scale and ambition of the business,” he stated. “The appointment of Bowsprit Partners reflects the next step in strengthening our advisory support as we execute our strategic roadmap.” This highlights a conscious effort to align financial muscle with the sophisticated advisory needed to deploy it effectively on the world stage.

Building a Fortress of Governance and Investor Trust

For a growing company on a public exchange like Euronext Growth—a market designed for small and medium-sized enterprises (SMEs)—building investor confidence is paramount. The appointment of Bowsprit Partners is as much about governance as it is about growth. As a mandatory requirement, companies on Euronext Growth must retain a Euronext Growth Advisor, or Listing Sponsor, to guide them through the market's regulatory landscape. Bowsprit Partners fulfills this crucial role.

This move is particularly significant given the increased regulatory scrutiny that can accompany rapid growth and market activity. By voluntarily enhancing its advisory infrastructure, Rapid Nutrition aims to ensure its public company framework is not just compliant but exemplary. The goal is to attract a broader and more sophisticated institutional investor base that prioritizes transparency, strong governance, and clear communication.

Bowsprit Partners will advise on capital markets strategy, investor communications, and the complex web of regulations relevant to a company with a growing international footprint. This proactive stance on governance is designed to create a stable and predictable environment for long-term shareholders, assuring them that the company's internal structures are maturing in lockstep with its external ambitions.

The Rise of Specialized Advisory on Europe's Growth Markets

Rapid Nutrition’s decision reflects a broader trend across European growth markets. SMEs are increasingly turning to specialized advisory boutiques like Bowsprit Partners to navigate the complexities of being a public entity. These firms offer a depth of expertise that is often essential for smaller companies that may lack large, in-house corporate finance and investor relations teams. The challenges are numerous, from adhering to the Market Abuse Regulation (MAR) to managing continuous disclosure obligations and competing for capital against larger, more established players.

Bowsprit Partners brings a wealth of relevant experience. Beyond its status as a Euronext Listing Sponsor, the firm is a Certified Adviser for the Nasdaq First North Growth Market, a Corporate Adviser for the Aquis Stock Exchange (AQSE), and a member firm of the London Stock Exchange. This multi-exchange accreditation makes it an ideal partner for a company like Rapid Nutrition with cross-border operations and ambitions. Bowsprit's portfolio, which spans sectors from technology to agriculture across various European exchanges, demonstrates its capability in managing diverse and complex corporate mandates.

By engaging such a partner, growth-stage companies can punch above their weight, accessing senior-level advice on everything from equity and debt fundraising to mergers and acquisitions. This support system is becoming a critical component of the ecosystem for European SMEs, enabling them to leverage public markets effectively to fuel their growth without getting derailed by regulatory or strategic missteps.

Executing the HealthTech Vision

With a strengthened financial foundation and an enhanced advisory team in place, the focus for Rapid Nutrition now shifts squarely to execution. The company is actively working to expand its product lines with new formats, such as on-the-go nutritional snacks, and is developing localized product formulas for specific markets like China to cater to local tastes and optimize profit margins.

The core of its forward-looking strategy lies in its HealthTech platform, which promises to deliver personalized nutrition solutions based on scientific research and advanced technology. This positions the company at the intersection of several high-growth trends: personalized health, digital wellness, and evidence-based nutrition. The successful implementation of this vision will be the ultimate measure of the recent strategic moves.

As Rapid Nutrition continues its international rollout and engages with a wider investor audience, the support from Bowsprit Partners will be instrumental in navigating market dynamics and maintaining the disciplined approach championed by its leadership. The coming months will be a critical test of this newly fortified structure as the company works to translate its strategic blueprint into tangible growth and shareholder value in 2026.